Table of Content

1 Report Overview
1.1 Insomnia Medication Definition
1.2 Market by Type
1.2.1 Global Insomnia Medication Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Nonbenzodiazepine Receptor Agonists
1.2.3 Benzodiazepine Receptor Agonists
1.2.4 The Selective Melatonin Receptor Agonist Ramelteon
1.2.5 Sedating Antidepressants
1.3 Market Segment by Application
1.3.1 Global Insomnia Medication Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Adults
1.3.3 Kids
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Insomnia Medication Sales
2.1 Global Insomnia Medication Revenue Estimates and Forecasts 2018-2034
2.2 Global Insomnia Medication Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Insomnia Medication Revenue by Region
2.3.1 Global Insomnia Medication Revenue by Region (2018-2024)
2.3.2 Global Insomnia Medication Revenue by Region (2024-2034)
2.4 Global Insomnia Medication Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Insomnia Medication Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Insomnia Medication Sales Quantity by Region
2.6.1 Global Insomnia Medication Sales Quantity by Region (2018-2024)
2.6.2 Global Insomnia Medication Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Insomnia Medication Sales Quantity by Manufacturers
3.1.1 Global Insomnia Medication Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Insomnia Medication Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Insomnia Medication Sales in 2022
3.2 Global Insomnia Medication Revenue by Manufacturers
3.2.1 Global Insomnia Medication Revenue by Manufacturers (2018-2024)
3.2.2 Global Insomnia Medication Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Insomnia Medication Revenue in 2022
3.3 Global Insomnia Medication Sales Price by Manufacturers
3.4 Global Key Players of Insomnia Medication, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Insomnia Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Insomnia Medication, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Insomnia Medication, Product Offered and Application
3.8 Global Key Manufacturers of Insomnia Medication, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Insomnia Medication Sales Quantity by Type
4.1.1 Global Insomnia Medication Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Insomnia Medication Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Insomnia Medication Sales Quantity Market Share by Type (2018-2034)
4.2 Global Insomnia Medication Revenue by Type
4.2.1 Global Insomnia Medication Historical Revenue by Type (2018-2024)
4.2.2 Global Insomnia Medication Forecasted Revenue by Type (2024-2034)
4.2.3 Global Insomnia Medication Revenue Market Share by Type (2018-2034)
4.3 Global Insomnia Medication Price by Type
4.3.1 Global Insomnia Medication Price by Type (2018-2024)
4.3.2 Global Insomnia Medication Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Insomnia Medication Sales Quantity by Application
5.1.1 Global Insomnia Medication Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Insomnia Medication Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Insomnia Medication Sales Quantity Market Share by Application (2018-2034)
5.2 Global Insomnia Medication Revenue by Application
5.2.1 Global Insomnia Medication Historical Revenue by Application (2018-2024)
5.2.2 Global Insomnia Medication Forecasted Revenue by Application (2024-2034)
5.2.3 Global Insomnia Medication Revenue Market Share by Application (2018-2034)
5.3 Global Insomnia Medication Price by Application
5.3.1 Global Insomnia Medication Price by Application (2018-2024)
5.3.2 Global Insomnia Medication Price Forecast by Application (2024-2034)
6 North America
6.1 North America Insomnia Medication Sales by Company
6.1.1 North America Insomnia Medication Revenue by Company (2018-2024)
6.1.2 North America Insomnia Medication Sales Quantity by Company (2018-2024)
6.2 North America Insomnia Medication Market Size by Type
6.2.1 North America Insomnia Medication Sales Quantity by Type (2018-2034)
6.2.2 North America Insomnia Medication Revenue by Type (2018-2034)
6.3 North America Insomnia Medication Market Size by Application
6.3.1 North America Insomnia Medication Sales Quantity by Application (2018-2034)
6.3.2 North America Insomnia Medication Revenue by Application (2018-2034)
6.4 North America Insomnia Medication Market Size by Country
6.4.1 North America Insomnia Medication Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Insomnia Medication Revenue by Country (2018-2034)
6.4.3 North America Insomnia Medication Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Insomnia Medication Sales by Company
7.1.1 Europe Insomnia Medication Sales Quantity by Company (2018-2024)
7.1.2 Europe Insomnia Medication Revenue by Company (2018-2024)
7.2 Europe Insomnia Medication Market Size by Type
7.2.1 Europe Insomnia Medication Sales Quantity by Type (2018-2034)
7.2.2 Europe Insomnia Medication Revenue by Type (2018-2034)
7.3 Europe Insomnia Medication Market Size by Application
7.3.1 Europe Insomnia Medication Sales Quantity by Application (2018-2034)
7.3.2 Europe Insomnia Medication Revenue by Application (2018-2034)
7.4 Europe Insomnia Medication Market Size by Country
7.4.1 Europe Insomnia Medication Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Insomnia Medication Revenue by Country (2018-2034)
7.4.3 Europe Insomnia Medication Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Insomnia Medication Sales by Company
8.1.1 China Insomnia Medication Sales Quantity by Company (2018-2024)
8.1.2 China Insomnia Medication Revenue by Company (2018-2024)
8.2 China Insomnia Medication Market Size by Type
8.2.1 China Insomnia Medication Sales Quantity by Type (2018-2034)
8.2.2 China Insomnia Medication Revenue by Type (2018-2034)
8.3 China Insomnia Medication Market Size by Application
8.3.1 China Insomnia Medication Sales Quantity by Application (2018-2034)
8.3.2 China Insomnia Medication Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Insomnia Medication Sales by Company
9.1.1 APAC Insomnia Medication Sales Quantity by Company (2018-2024)
9.1.2 APAC Insomnia Medication Revenue by Company (2018-2024)
9.2 APAC Insomnia Medication Market Size by Type
9.2.1 APAC Insomnia Medication Sales Quantity by Type (2018-2034)
9.2.2 APAC Insomnia Medication Revenue by Type (2018-2034)
9.3 APAC Insomnia Medication Market Size by Application
9.3.1 APAC Insomnia Medication Sales Quantity by Application (2018-2034)
9.3.2 APAC Insomnia Medication Revenue by Application (2018-2034)
9.4 APAC Insomnia Medication Market Size by Region
9.4.1 APAC Insomnia Medication Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Insomnia Medication Revenue by Region (2018-2034)
9.4.3 APAC Insomnia Medication Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Insomnia Medication Sales by Company
10.1.1 Middle East, Africa and Latin America Insomnia Medication Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Insomnia Medication Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Insomnia Medication Market Size by Type
10.2.1 Middle East, Africa and Latin America Insomnia Medication Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Insomnia Medication Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Insomnia Medication Market Size by Application
10.3.1 Middle East, Africa and Latin America Insomnia Medication Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Insomnia Medication Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Insomnia Medication Market Size by Country
10.4.1 Middle East, Africa and Latin America Insomnia Medication Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Insomnia Medication Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Insomnia Medication Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Eisai
11.1.1 Eisai Company Information
11.1.2 Eisai Overview
11.1.3 Eisai Insomnia Medication Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Eisai Insomnia Medication Products and Services
11.1.5 Eisai Insomnia Medication SWOT Analysis
11.1.6 Eisai Recent Developments
11.2 Merck
11.2.1 Merck Company Information
11.2.2 Merck Overview
11.2.3 Merck Insomnia Medication Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Merck Insomnia Medication Products and Services
11.2.5 Merck Insomnia Medication SWOT Analysis
11.2.6 Merck Recent Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Overview
11.3.3 Pfizer Insomnia Medication Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Pfizer Insomnia Medication Products and Services
11.3.5 Pfizer Insomnia Medication SWOT Analysis
11.3.6 Pfizer Recent Developments
11.4 Sanofi
11.4.1 Sanofi Company Information
11.4.2 Sanofi Overview
11.4.3 Sanofi Insomnia Medication Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Sanofi Insomnia Medication Products and Services
11.4.5 Sanofi Insomnia Medication SWOT Analysis
11.4.6 Sanofi Recent Developments
11.5 Takeda
11.5.1 Takeda Company Information
11.5.2 Takeda Overview
11.5.3 Takeda Insomnia Medication Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Takeda Insomnia Medication Products and Services
11.5.5 Takeda Insomnia Medication SWOT Analysis
11.5.6 Takeda Recent Developments
11.6 Vanda Pharmaceuticals
11.6.1 Vanda Pharmaceuticals Company Information
11.6.2 Vanda Pharmaceuticals Overview
11.6.3 Vanda Pharmaceuticals Insomnia Medication Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Vanda Pharmaceuticals Insomnia Medication Products and Services
11.6.5 Vanda Pharmaceuticals Insomnia Medication SWOT Analysis
11.6.6 Vanda Pharmaceuticals Recent Developments
11.7 Astellas
11.7.1 Astellas Company Information
11.7.2 Astellas Overview
11.7.3 Astellas Insomnia Medication Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 Astellas Insomnia Medication Products and Services
11.7.5 Astellas Insomnia Medication SWOT Analysis
11.7.6 Astellas Recent Developments
11.8 Dainippon Sumitomo
11.8.1 Dainippon Sumitomo Company Information
11.8.2 Dainippon Sumitomo Overview
11.8.3 Dainippon Sumitomo Insomnia Medication Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 Dainippon Sumitomo Insomnia Medication Products and Services
11.8.5 Dainippon Sumitomo Insomnia Medication SWOT Analysis
11.8.6 Dainippon Sumitomo Recent Developments
11.9 ECR Pharmaceuticals (Valeant)
11.9.1 ECR Pharmaceuticals (Valeant) Company Information
11.9.2 ECR Pharmaceuticals (Valeant) Overview
11.9.3 ECR Pharmaceuticals (Valeant) Insomnia Medication Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 ECR Pharmaceuticals (Valeant) Insomnia Medication Products and Services
11.9.5 ECR Pharmaceuticals (Valeant) Insomnia Medication SWOT Analysis
11.9.6 ECR Pharmaceuticals (Valeant) Recent Developments
11.10 Flynn Pharma
11.10.1 Flynn Pharma Company Information
11.10.2 Flynn Pharma Overview
11.10.3 Flynn Pharma Insomnia Medication Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.10.4 Flynn Pharma Insomnia Medication Products and Services
11.10.5 Flynn Pharma Insomnia Medication SWOT Analysis
11.10.6 Flynn Pharma Recent Developments
11.11 Johnson & Johnson
11.11.1 Johnson & Johnson Company Information
11.11.2 Johnson & Johnson Overview
11.11.3 Johnson & Johnson Insomnia Medication Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.11.4 Johnson & Johnson Insomnia Medication Products and Services
11.11.5 Johnson & Johnson Recent Developments
11.12 Meda
11.12.1 Meda Company Information
11.12.2 Meda Overview
11.12.3 Meda Insomnia Medication Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.12.4 Meda Insomnia Medication Products and Services
11.12.5 Meda Recent Developments
11.13 Somnus Therapeutics
11.13.1 Somnus Therapeutics Company Information
11.13.2 Somnus Therapeutics Overview
11.13.3 Somnus Therapeutics Insomnia Medication Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.13.4 Somnus Therapeutics Insomnia Medication Products and Services
11.13.5 Somnus Therapeutics Recent Developments
11.14 Purdue Pharma
11.14.1 Purdue Pharma Company Information
11.14.2 Purdue Pharma Overview
11.14.3 Purdue Pharma Insomnia Medication Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.14.4 Purdue Pharma Insomnia Medication Products and Services
11.14.5 Purdue Pharma Recent Developments
11.15 Neurim
11.15.1 Neurim Company Information
11.15.2 Neurim Overview
11.15.3 Neurim Insomnia Medication Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.15.4 Neurim Insomnia Medication Products and Services
11.15.5 Neurim Recent Developments
11.16 Minerva Neurosciences
11.16.1 Minerva Neurosciences Company Information
11.16.2 Minerva Neurosciences Overview
11.16.3 Minerva Neurosciences Insomnia Medication Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.16.4 Minerva Neurosciences Insomnia Medication Products and Services
11.16.5 Minerva Neurosciences Recent Developments
11.17 Pernix Therapeutics
11.17.1 Pernix Therapeutics Company Information
11.17.2 Pernix Therapeutics Overview
11.17.3 Pernix Therapeutics Insomnia Medication Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.17.4 Pernix Therapeutics Insomnia Medication Products and Services
11.17.5 Pernix Therapeutics Recent Developments
11.18 SkyePharma
11.18.1 SkyePharma Company Information
11.18.2 SkyePharma Overview
11.18.3 SkyePharma Insomnia Medication Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.18.4 SkyePharma Insomnia Medication Products and Services
11.18.5 SkyePharma Recent Developments
11.19 Paratek Pharmaceuticals
11.19.1 Paratek Pharmaceuticals Company Information
11.19.2 Paratek Pharmaceuticals Overview
11.19.3 Paratek Pharmaceuticals Insomnia Medication Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.19.4 Paratek Pharmaceuticals Insomnia Medication Products and Services
11.19.5 Paratek Pharmaceuticals Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Insomnia Medication Value Chain Analysis
12.2 Insomnia Medication Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Insomnia Medication Production Mode & Process
12.4 Insomnia Medication Sales and Marketing
12.4.1 Insomnia Medication Sales Channels
12.4.2 Insomnia Medication Distributors
12.5 Insomnia Medication Customers
13 Market Dynamics
13.1 Insomnia Medication Industry Trends
13.2 Insomnia Medication Market Drivers
13.3 Insomnia Medication Market Challenges
13.4 Insomnia Medication Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Insomnia Medication Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Nonbenzodiazepine Receptor Agonists
Table 3. Major Manufacturers of Benzodiazepine Receptor Agonists
Table 4. Major Manufacturers of The Selective Melatonin Receptor Agonist Ramelteon
Table 5. Major Manufacturers of Sedating Antidepressants
Table 6. Global Insomnia Medication Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Insomnia Medication Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global Insomnia Medication Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Insomnia Medication Revenue Market Share by Region (2018-2024)
Table 10. Global Insomnia Medication Revenue by Region (2024-2034) & (US$ Million)
Table 11. Global Insomnia Medication Revenue Market Share by Region (2024-2034)
Table 12. Global Insomnia Medication Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Pcs)
Table 13. Global Insomnia Medication Sales by Region (2018-2024) & (K Pcs)
Table 14. Global Insomnia Medication Sales Market Share by Region (2018-2024)
Table 15. Global Insomnia Medication Sales by Region (2024-2034) & (K Pcs)
Table 16. Global Insomnia Medication Sales Market Share by Region (2024-2034)
Table 17. Global Insomnia Medication Sales Quantity by Manufacturers (2018-2024) & (K Pcs)
Table 18. Global Insomnia Medication Sales Quantity Share by Manufacturers (2018-2024)
Table 19. Global Insomnia Medication Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Insomnia Medication Revenue Share by Manufacturers (2018-2024)
Table 21. Global Insomnia Medication Price by Manufacturers 2018-2024 (USD/Pcs)
Table 22. Global Key Players of Insomnia Medication, Industry Ranking, 2021 VS 2022
Table 23. Global Insomnia Medication Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Insomnia Medication by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insomnia Medication as of 2022)
Table 25. Global Key Manufacturers of Insomnia Medication, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Insomnia Medication, Product Offered and Application
Table 27. Global Key Manufacturers of Insomnia Medication, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Insomnia Medication Sales Quantity by Type (2018-2024) & (K Pcs)
Table 30. Global Insomnia Medication Sales Quantity by Type (2024-2034) & (K Pcs)
Table 31. Global Insomnia Medication Sales Quantity Share by Type (2018-2024)
Table 32. Global Insomnia Medication Sales Quantity Share by Type (2024-2034)
Table 33. Global Insomnia Medication Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Insomnia Medication Revenue by Type (2024-2034) & (US$ Million)
Table 35. Global Insomnia Medication Revenue Share by Type (2018-2024)
Table 36. Global Insomnia Medication Revenue Share by Type (2024-2034)
Table 37. Insomnia Medication Price by Type (2018-2024) & (USD/Pcs)
Table 38. Global Insomnia Medication Price Forecast by Type (2024-2034) & (USD/Pcs)
Table 39. Global Insomnia Medication Sales Quantity by Application (2018-2024) & (K Pcs)
Table 40. Global Insomnia Medication Sales Quantity by Application (2024-2034) & (K Pcs)
Table 41. Global Insomnia Medication Sales Quantity Share by Application (2018-2024)
Table 42. Global Insomnia Medication Sales Quantity Share by Application (2024-2034)
Table 43. Global Insomnia Medication Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Insomnia Medication Revenue by Application (2024-2034) & (US$ Million)
Table 45. Global Insomnia Medication Revenue Share by Application (2018-2024)
Table 46. Global Insomnia Medication Revenue Share by Application (2024-2034)
Table 47. Insomnia Medication Price by Application (2018-2024) & (USD/Pcs)
Table 48. Global Insomnia Medication Price Forecast by Application (2024-2034) & (USD/Pcs)
Table 49. North America Insomnia Medication Revenue by Company (2018-2024) & (US$ Million)
Table 50. North America Insomnia Medication Sales Quantity by Company (2018-2024) & (K Pcs)
Table 51. North America Insomnia Medication Sales Quantity by Type (2018-2024) & (K Pcs)
Table 52. North America Insomnia Medication Sales Quantity by Type (2024-2034) & (K Pcs)
Table 53. North America Insomnia Medication Revenue by Type (2018-2024) & (US$ Million)
Table 54. North America Insomnia Medication Revenue by Type (2024-2034) & (US$ Million)
Table 55. North America Insomnia Medication Sales Quantity by Application (2018-2024) & (K Pcs)
Table 56. North America Insomnia Medication Sales Quantity by Application (2024-2034) & (K Pcs)
Table 57. North America Insomnia Medication Revenue by Application (2018-2024) & (US$ Million)
Table 58. North America Insomnia Medication Revenue by Application (2024-2034) & (US$ Million)
Table 59. North America Insomnia Medication Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 60. North America Insomnia Medication Revenue by Country (2018-2024) & (US$ Million)
Table 61. North America Insomnia Medication Revenue by Country (2024-2034) & (US$ Million)
Table 62. North America Insomnia Medication Sales Quantity by Country (2018-2024) & (K Pcs)
Table 63. North America Insomnia Medication Sales Quantity by Country (2024-2034) & (K Pcs)
Table 64. Europe Insomnia Medication Sales Quantity by Company (2018-2024) & (K Pcs)
Table 65. Europe Insomnia Medication Revenue by Company (2018-2024) & (US$ Million)
Table 66. Europe Insomnia Medication Sales Quantity by Type (2018-2024) & (K Pcs)
Table 67. Europe Insomnia Medication Sales Quantity by Type (2024-2034) & (K Pcs)
Table 68. Europe Insomnia Medication Revenue by Type (2018-2024) & (US$ Million)
Table 69. Europe Insomnia Medication Revenue by Type (2024-2034) & (US$ Million)
Table 70. Europe Insomnia Medication Sales Quantity by Application (2018-2024) & (K Pcs)
Table 71. Europe Insomnia Medication Sales Quantity by Application (2024-2034) & (K Pcs)
Table 72. Europe Insomnia Medication Revenue by Application (2018-2024) & (US$ Million)
Table 73. Europe Insomnia Medication Revenue by Application (2024-2034) & (US$ Million)
Table 74. Europe Insomnia Medication Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 75. Europe Insomnia Medication Revenue by Country (2018-2024) & (US$ Million)
Table 76. Europe Insomnia Medication Revenue by Country (2024-2034) & (US$ Million)
Table 77. Europe Insomnia Medication Sales Quantity by Country (2018-2024) & (K Pcs)
Table 78. Europe Insomnia Medication Sales Quantity by Country (2024-2034) & (K Pcs)
Table 79. China Insomnia Medication Sales Quantity by Company (2018-2024) & (K Pcs)
Table 80. China Insomnia Medication Revenue by Company (2018-2024) & (US$ Million)
Table 81. China Insomnia Medication Sales Quantity by Type (2018-2024) & (K Pcs)
Table 82. China Insomnia Medication Sales Quantity by Type (2024-2034) & (K Pcs)
Table 83. China Insomnia Medication Revenue by Type (2018-2024) & (US$ Million)
Table 84. China Insomnia Medication Revenue by Type (2024-2034) & (US$ Million)
Table 85. China Insomnia Medication Sales Quantity by Application (2018-2024) & (K Pcs)
Table 86. China Insomnia Medication Sales Quantity by Application (2024-2034) & (K Pcs)
Table 87. China Insomnia Medication Revenue by Application (2018-2024) & (US$ Million)
Table 88. China Insomnia Medication Revenue by Application (2024-2034) & (US$ Million)
Table 89. APAC Insomnia Medication Sales Quantity by Company (2018-2024) & (K Pcs)
Table 90. APAC Insomnia Medication Revenue by Company (2018-2024) & (US$ Million)
Table 91. APAC Insomnia Medication Sales Quantity by Type (2018-2024) & (K Pcs)
Table 92. APAC Insomnia Medication Sales Quantity by Type (2024-2034) & (K Pcs)
Table 93. APAC Insomnia Medication Revenue by Type (2018-2024) & (US$ Million)
Table 94. APAC Insomnia Medication Revenue by Type (2024-2034) & (US$ Million)
Table 95. APAC Insomnia Medication Sales Quantity by Application (2018-2024) & (K Pcs)
Table 96. APAC Insomnia Medication Sales Quantity by Application (2024-2034) & (K Pcs)
Table 97. APAC Insomnia Medication Revenue by Application (2018-2024) & (US$ Million)
Table 98. APAC Insomnia Medication Revenue by Application (2024-2034) & (US$ Million)
Table 99. APAC Insomnia Medication Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 100. APAC Insomnia Medication Revenue by Region (2018-2024) & (US$ Million)
Table 101. APAC Insomnia Medication Revenue by Region (2024-2034) & (US$ Million)
Table 102. APAC Insomnia Medication Sales Quantity by Region (2018-2024) & (K Pcs)
Table 103. APAC Insomnia Medication Sales Quantity by Region (2024-2034) & (K Pcs)
Table 104. Middle East, Africa and Latin America Insomnia Medication Sales Quantity by Company (2018-2024) & (K Pcs)
Table 105. Middle East, Africa and Latin America Insomnia Medication Revenue by Company (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Insomnia Medication Sales Quantity by Type (2018-2024) & (K Pcs)
Table 107. Middle East, Africa and Latin America Insomnia Medication Sales Quantity by Type (2024-2034) & (K Pcs)
Table 108. Middle East, Africa and Latin America Insomnia Medication Revenue by Type (2018-2024) & (US$ Million)
Table 109. Middle East, Africa and Latin America Insomnia Medication Revenue by Type (2024-2034) & (US$ Million)
Table 110. Middle East, Africa and Latin America Insomnia Medication Sales Quantity by Application (2018-2024) & (K Pcs)
Table 111. Middle East, Africa and Latin America Insomnia Medication Sales Quantity by Application (2024-2034) & (K Pcs)
Table 112. Middle East, Africa and Latin America Insomnia Medication Revenue by Application (2018-2024) & (US$ Million)
Table 113. Middle East, Africa and Latin America Insomnia Medication Revenue by Application (2024-2034) & (US$ Million)
Table 114. Middle East, Africa and Latin America Insomnia Medication Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 115. Middle East, Africa and Latin America Insomnia Medication Revenue by Country (2018-2024) & (US$ Million)
Table 116. Middle East, Africa and Latin America Insomnia Medication Revenue by Country (2024-2034) & (US$ Million)
Table 117. Middle East, Africa and Latin America Insomnia Medication Sales Quantity by Country (2018-2024) & (K Pcs)
Table 118. Middle East, Africa and Latin America Insomnia Medication Sales Quantity by Country (2024-2034) & (K Pcs)
Table 119. Eisai Company Information
Table 120. Eisai Description and Overview
Table 121. Eisai Insomnia Medication Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 122. Eisai Insomnia Medication Product and Services
Table 123. Eisai Insomnia Medication SWOT Analysis
Table 124. Eisai Recent Developments
Table 125. Merck Company Information
Table 126. Merck Description and Overview
Table 127. Merck Insomnia Medication Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 128. Merck Insomnia Medication Product and Services
Table 129. Merck Insomnia Medication SWOT Analysis
Table 130. Merck Recent Developments
Table 131. Pfizer Company Information
Table 132. Pfizer Description and Overview
Table 133. Pfizer Insomnia Medication Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 134. Pfizer Insomnia Medication Product and Services
Table 135. Pfizer Insomnia Medication SWOT Analysis
Table 136. Pfizer Recent Developments
Table 137. Sanofi Company Information
Table 138. Sanofi Description and Overview
Table 139. Sanofi Insomnia Medication Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 140. Sanofi Insomnia Medication Product and Services
Table 141. Sanofi Insomnia Medication SWOT Analysis
Table 142. Sanofi Recent Developments
Table 143. Takeda Company Information
Table 144. Takeda Description and Overview
Table 145. Takeda Insomnia Medication Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 146. Takeda Insomnia Medication Product and Services
Table 147. Takeda Insomnia Medication SWOT Analysis
Table 148. Takeda Recent Developments
Table 149. Vanda Pharmaceuticals Company Information
Table 150. Vanda Pharmaceuticals Description and Overview
Table 151. Vanda Pharmaceuticals Insomnia Medication Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 152. Vanda Pharmaceuticals Insomnia Medication Product and Services
Table 153. Vanda Pharmaceuticals Insomnia Medication SWOT Analysis
Table 154. Vanda Pharmaceuticals Recent Developments
Table 155. Astellas Company Information
Table 156. Astellas Description and Overview
Table 157. Astellas Insomnia Medication Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 158. Astellas Insomnia Medication Product and Services
Table 159. Astellas Insomnia Medication SWOT Analysis
Table 160. Astellas Recent Developments
Table 161. Dainippon Sumitomo Company Information
Table 162. Dainippon Sumitomo Description and Overview
Table 163. Dainippon Sumitomo Insomnia Medication Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 164. Dainippon Sumitomo Insomnia Medication Product and Services
Table 165. Dainippon Sumitomo Insomnia Medication SWOT Analysis
Table 166. Dainippon Sumitomo Recent Developments
Table 167. ECR Pharmaceuticals (Valeant) Company Information
Table 168. ECR Pharmaceuticals (Valeant) Description and Overview
Table 169. ECR Pharmaceuticals (Valeant) Insomnia Medication Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 170. ECR Pharmaceuticals (Valeant) Insomnia Medication Product and Services
Table 171. ECR Pharmaceuticals (Valeant) Insomnia Medication SWOT Analysis
Table 172. ECR Pharmaceuticals (Valeant) Recent Developments
Table 173. Flynn Pharma Company Information
Table 174. Flynn Pharma Description and Overview
Table 175. Flynn Pharma Insomnia Medication Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 176. Flynn Pharma Insomnia Medication Product and Services
Table 177. Flynn Pharma Insomnia Medication SWOT Analysis
Table 178. Flynn Pharma Recent Developments
Table 179. Johnson & Johnson Company Information
Table 180. Johnson & Johnson Description and Overview
Table 181. Johnson & Johnson Insomnia Medication Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 182. Johnson & Johnson Insomnia Medication Product and Services
Table 183. Johnson & Johnson Recent Developments
Table 184. Meda Company Information
Table 185. Meda Description and Overview
Table 186. Meda Insomnia Medication Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 187. Meda Insomnia Medication Product and Services
Table 188. Meda Recent Developments
Table 189. Somnus Therapeutics Company Information
Table 190. Somnus Therapeutics Description and Overview
Table 191. Somnus Therapeutics Insomnia Medication Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 192. Somnus Therapeutics Insomnia Medication Product and Services
Table 193. Somnus Therapeutics Recent Developments
Table 194. Purdue Pharma Company Information
Table 195. Purdue Pharma Description and Overview
Table 196. Purdue Pharma Insomnia Medication Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 197. Purdue Pharma Insomnia Medication Product and Services
Table 198. Purdue Pharma Recent Developments
Table 199. Neurim Company Information
Table 200. Neurim Description and Overview
Table 201. Neurim Insomnia Medication Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 202. Neurim Insomnia Medication Product and Services
Table 203. Neurim Recent Developments
Table 204. Minerva Neurosciences Company Information
Table 205. Minerva Neurosciences Description and Overview
Table 206. Minerva Neurosciences Insomnia Medication Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 207. Minerva Neurosciences Insomnia Medication Product and Services
Table 208. Minerva Neurosciences Recent Developments
Table 209. Pernix Therapeutics Company Information
Table 210. Pernix Therapeutics Description and Overview
Table 211. Pernix Therapeutics Insomnia Medication Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 212. Pernix Therapeutics Insomnia Medication Product and Services
Table 213. Pernix Therapeutics Recent Developments
Table 214. SkyePharma Company Information
Table 215. SkyePharma Description and Overview
Table 216. SkyePharma Insomnia Medication Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 217. SkyePharma Insomnia Medication Product and Services
Table 218. SkyePharma Recent Developments
Table 219. Paratek Pharmaceuticals Company Information
Table 220. Paratek Pharmaceuticals Description and Overview
Table 221. Paratek Pharmaceuticals Insomnia Medication Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2018-2024)
Table 222. Paratek Pharmaceuticals Insomnia Medication Product and Services
Table 223. Paratek Pharmaceuticals Recent Developments
Table 224. Key Raw Materials Lists
Table 225. Raw Materials Key Suppliers Lists
Table 226. Insomnia Medication Distributors List
Table 227. Insomnia Medication Customers List
Table 228. Insomnia Medication Market Trends
Table 229. Insomnia Medication Market Drivers
Table 230. Insomnia Medication Market Challenges
Table 231. Insomnia Medication Market Restraints
Table 232. Research Programs/Design for This Report
Table 233. Key Data Information from Secondary Sources
Table 234. Key Data Information from Primary Sources
List of Figures
Figure 1. Insomnia Medication Product Picture
Figure 2. Global Insomnia Medication Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Insomnia Medication Market Share by Type in 2022 & 2034
Figure 4. Nonbenzodiazepine Receptor Agonists Product Picture
Figure 5. Benzodiazepine Receptor Agonists Product Picture
Figure 6. The Selective Melatonin Receptor Agonist Ramelteon Product Picture
Figure 7. Sedating Antidepressants Product Picture
Figure 8. Global Insomnia Medication Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 9. Global Insomnia Medication Market Share by Application in 2022 & 2034
Figure 10. Adults
Figure 11. Kids
Figure 12. Insomnia Medication Report Years Considered
Figure 13. Global Insomnia Medication Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 14. Global Insomnia Medication Revenue 2018-2034 (US$ Million)
Figure 15. Global Insomnia Medication Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 16. Global Insomnia Medication Sales Quantity 2018-2034 (K Pcs)
Figure 17. Global Insomnia Medication Sales Quantity Market Share by Region (2018-2024)
Figure 18. Global Insomnia Medication Sales Quantity Market Share by Region (2024-2034)
Figure 19. North America Insomnia Medication Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 20. North America Insomnia Medication Revenue YoY (2018-2034) & (US$ Million)
Figure 21. Europe Insomnia Medication Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 22. Europe Insomnia Medication Revenue YoY (2018-2034) & (US$ Million)
Figure 23. China Insomnia Medication Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 24. China Insomnia Medication Revenue YoY (2018-2034) & (US$ Million)
Figure 25. APAC Insomnia Medication Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 26. APAC Insomnia Medication Revenue YoY (2018-2034) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Insomnia Medication Sales Quantity YoY (2018-2034) & (K Pcs)
Figure 28. Middle East, Africa and Latin America Insomnia Medication Revenue YoY (2018-2034) & (US$ Million)
Figure 29. The Top 10 and Top 5 Players Market Share by Insomnia Medication Sales Quantity in 2022
Figure 30. The Top 10 and Top 5 Players Market Share by Insomnia Medication Revenue in 2022
Figure 31. Insomnia Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Insomnia Medication Sales Quantity Market Share by Type (2018-2034)
Figure 33. Global Insomnia Medication Revenue Market Share by Type (2018-2034)
Figure 34. Global Insomnia Medication Sales Quantity Market Share by Application (2018-2034)
Figure 35. Global Insomnia Medication Revenue Market Share by Application (2018-2034)
Figure 36. North America Insomnia Medication Revenue Market Share by Company in 2022
Figure 37. North America Insomnia Medication Sales Quantity Market Share by Company in 2022
Figure 38. North America Insomnia Medication Sales Quantity Market Share by Type (2018-2034)
Figure 39. North America Insomnia Medication Revenue Market Share by Type (2018-2034)
Figure 40. North America Insomnia Medication Sales Quantity Market Share by Application (2018-2034)
Figure 41. North America Insomnia Medication Revenue Market Share by Application (2018-2034)
Figure 42. North America Insomnia Medication Revenue Share by Country (2018-2034)
Figure 43. North America Insomnia Medication Sales Quantity Share by Country (2018-2034)
Figure 44. U.S. Insomnia Medication Revenue (2018-2034) & (US$ Million)
Figure 45. Canada Insomnia Medication Revenue (2018-2034) & (US$ Million)
Figure 46. Europe Insomnia Medication Sales Quantity Market Share by Company in 2022
Figure 47. Europe Insomnia Medication Revenue Market Share by Company in 2022
Figure 48. Europe Insomnia Medication Sales Quantity Market Share by Type (2018-2034)
Figure 49. Europe Insomnia Medication Revenue Market Share by Type (2018-2034)
Figure 50. Europe Insomnia Medication Sales Quantity Market Share by Application (2018-2034)
Figure 51. Europe Insomnia Medication Revenue Market Share by Application (2018-2034)
Figure 52. Europe Insomnia Medication Revenue Share by Country (2018-2034)
Figure 53. Europe Insomnia Medication Sales Quantity Share by Country (2018-2034)
Figure 54. Germany Insomnia Medication Revenue (2018-2034) & (US$ Million)
Figure 55. France Insomnia Medication Revenue (2018-2034) & (US$ Million)
Figure 56. U.K. Insomnia Medication Revenue (2018-2034) & (US$ Million)
Figure 57. Italy Insomnia Medication Revenue (2018-2034) & (US$ Million)
Figure 58. Russia Insomnia Medication Revenue (2018-2034) & (US$ Million)
Figure 59. China Insomnia Medication Sales Quantity Market Share by Company in 2022
Figure 60. China Insomnia Medication Revenue Market Share by Company in 2022
Figure 61. China Insomnia Medication Sales Quantity Market Share by Type (2018-2034)
Figure 62. China Insomnia Medication Revenue Market Share by Type (2018-2034)
Figure 63. China Insomnia Medication Sales Quantity Market Share by Application (2018-2034)
Figure 64. China Insomnia Medication Revenue Market Share by Application (2018-2034)
Figure 65. APAC Insomnia Medication Sales Quantity Market Share by Company in 2022
Figure 66. APAC Insomnia Medication Revenue Market Share by Company in 2022
Figure 67. APAC Insomnia Medication Sales Quantity Market Share by Type (2018-2034)
Figure 68. APAC Insomnia Medication Revenue Market Share by Type (2018-2034)
Figure 69. APAC Insomnia Medication Sales Quantity Market Share by Application (2018-2034)
Figure 70. APAC Insomnia Medication Revenue Market Share by Application (2018-2034)
Figure 71. APAC Insomnia Medication Revenue Share by Region (2018-2034)
Figure 72. APAC Insomnia Medication Sales Quantity Share by Region (2018-2034)
Figure 73. Japan Insomnia Medication Revenue (2018-2034) & (US$ Million)
Figure 74. South Korea Insomnia Medication Revenue (2018-2034) & (US$ Million)
Figure 75. China Taiwan Insomnia Medication Revenue (2018-2034) & (US$ Million)
Figure 76. Southeast Asia Insomnia Medication Revenue (2018-2034) & (US$ Million)
Figure 77. India Insomnia Medication Revenue (2018-2034) & (US$ Million)
Figure 78. Middle East, Africa and Latin America Insomnia Medication Sales Quantity Market Share by Company in 2022
Figure 79. Middle East, Africa and Latin America Insomnia Medication Revenue Market Share by Company in 2022
Figure 80. Middle East, Africa and Latin America Insomnia Medication Sales Quantity Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America Insomnia Medication Revenue Market Share by Type (2018-2034)
Figure 82. Middle East, Africa and Latin America Insomnia Medication Sales Quantity Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America Insomnia Medication Revenue Market Share by Application (2018-2034)
Figure 84. Middle East, Africa and Latin America Insomnia Medication Sales Quantity Share by Country (2018-2034)
Figure 85. Middle East, Africa and Latin America Insomnia Medication Revenue Share by Country (2018-2034)
Figure 86. Brazil Insomnia Medication Revenue (2018-2034) & (US$ Million)
Figure 87. Mexico Insomnia Medication Revenue (2018-2034) & (US$ Million)
Figure 88. Turkey Insomnia Medication Revenue (2018-2034) & (US$ Million)
Figure 89. Israel Insomnia Medication Revenue (2018-2034) & (US$ Million)
Figure 90. GCC Countries Insomnia Medication Revenue (2018-2034) & (US$ Million)
Figure 91. Insomnia Medication Value Chain
Figure 92. Insomnia Medication Production Process
Figure 93. Channels of Distribution (Direct Vs Distribution)
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed